In Vivo Activities of Farnesyl Pyrophosphate Synthase Inhibitors against Leishmania donovani and Toxoplasma gondii

The in vivo activities of three bisphosphonates were determined against Leishmania donovani and Toxoplasma gondii. Alendronate was essentially inactive against both parasites. Pamidronate was active against L. donovani by intravenous administration. Risedronate had a 50% effective dosage of five 2.6...

Täydet tiedot

Bibliografiset tiedot

Julkaisussa:	Antimicrob Agents Chemother
Päätekijät:	Yardley, Vanessa, Khan, Anis A., Martin, Michael B., Slifer, Teri R., Araujo, Fausto G., Moreno, Silvia N. J., Docampo, Roberto, Croft, Simon L., Oldfield, Eric
Aineistotyyppi:	Artigo
Kieli:	Inglês
Julkaistu:	American Society for Microbiology (ASM) 2002
Aiheet:	Experimental Therapeutics
Linkit:	https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC127510/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/11850291/ https://ncbi.nlm.nih.govhttps://doi.org/10.1128/AAC.46.3.929-931.2002
Tagit:	Lisää tagi Ei tageja, Lisää ensimmäinen tagi!